Retinoic Acid, all trans CAS: 302-79-4
MF: C20H28O2
MW: 300.4
An activator of RAR and RXR and used in stem cells.

Retinoic Acid, all trans (CAS 302-79-4)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 135ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
5
1
4
0
3
0
2
0
1
0
Synonyme: Vitamin A acid
Application: An activator of RAR and RXR and used in stem cells
Numéro CAS: 302-79-4
Pureté: ≥98%
Masse Moléculaire: 300.4
Formule Moléculaire: C20H28O2
Supplemental Information: This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
* Consulter le Certificat d'Analyses pour les données spécifiques à un lot (incluant la teneur en eau).
Postez un avis sur ce produit et recevez 15 CruzCredits

Retinoic Acid, all trans is the oxidized carboxylic acid form of retinol, known in the dietary context as Vitamin A. Retinal (sc-210778) is the aldehyde form of retinol required by the retina of the eye for light absorption and visual processing. Retinoic acid and the other retinoids are involved in a broad range of biological regulations, mediating differentiation, proliferation, and apoptosis. Binding of Retinoic Acid to the nuclear receptors RAR (retinoic acid receptor) and the RXR (retinoid X receptor) initiate signals for transcription and development. The intimate relationship between retinoids and cell cycle regulation has been implicated in suppression of oncogenic proliferation. Also available in a photoactivatable, caged form (sc-202089).


Références

1. Leid, M., et al., 1992. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends in biochemical sciences. 17(10): 427-33. PMID: 1333659
2. Allenby, G., et al., 1994. Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors alpha, beta, and gamma. Retinoic acid receptor gamma binds all-trans-retinoic acid preferentially over 9-cis-retinoic acid. The Journal of biological chemistry. 269(24): 16689-95. PMID: 8206989
3. Napoli, J L., et al., 1996. Biochemical pathways of retinoid transport, metabolism, and signal transduction. Clinical immunology and immunopathology. 80(3 Pt 2): S52-62. PMID: 8811064
4. Bushue, Nathan., et al., 2010. Retinoid pathway and cancer therapeutics. Advanced drug delivery reviews. 62(13): 1285-98. PMID: 20654663

État Physique :
Solid
Solubilité :
Soluble in DMSO (25 mg/mL), ethanol (10 mg/mL), acetate, DMF (20 mg/mL), dimethyl sulfoxide (25 mg/mL), chloroform (40 mg/mL), methanol, acetone (30 mg/mL), and dichloromethane. Insoluble in water, and ether. It is recommended that solutions be made fresh for each use.
STOCKAGE :
Store at -20° C
Point de fusion :
180-181° C (lit.)
Point d'Ébullition :
~462.80° C at 760 mmHg (Predicted)
Densité :
1.01 g/cm3
Indice de Réfraction :
n20D 1.56
IC50 :
Retinoic acid receptor gamma: IC50 = 0.62 nM (human); Retinoic acid receptor alpha: IC50 = 5 nM (mus musculus); Herpesvirus 4: IC50 = 15.4 nM (human)
Ki Data :
Retinoic acid receptor gamma: Ki= 0.7 nM (human); Retinoic acid receptor beta: Ki= 0.5 nM (human); Retinoic acid receptor alpha: Ki= 0.1 nM (human)
Valeurs pK :
pKa: 4.73
Pour la Recherche Uniquement. Non conforme pour le Diagnostic ou pour une Utilisation Thérapeutique.
WGK Allemagne :
2
RTECS :
VH6475000
PubChem CID :
444795
Index Merck :
14: 8165
Numéro MDL :
MFCD00001551
Numéro CE :
206-129-0
Registre Beilstein :
2057223
SMILES :
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C

Télécharger la Fiche de Sécurité/ SDS (MSDS)

CERTIFICAT D'ANALYSE

Pour une bonne lecture, Adobe Acrobat Reader est requis,
imprimer et commenter les documents PDF

Retinoic Acid, all trans  Références bibliographiques

Consultez les publications faisant référence à l' utilisation de Retinoic Acid, all trans. Cliquez sur le lien pour afficher lentrée PubMed .

Citations 1 à 10 sur un total de 12

PMID: # 29072505  Pastorková, B. et al. 2017. Drug Chem Toxicol. 41: 1-7.

PMID: # 26345577  Briceño, A. et al. 2016. Neurotox Res. 29: 381-93.

PMID: # 26898150  Venne, P. et al. 2016. J Chromatogr A. 1438: 57-64.

PMID: # 26208032  Illés, P. et al. 2015. J. Agric. Food Chem. 63: 7074-83.

PMID: # 20547768  Apostolatos, H. et al. 2010. J Biol Chem. -.

PMID: # 20096012  Britschgi, A. et al. 2010. Br. J. Haematol. 149: 55-64.

PMID: # 18511453  Wang, C. et al. 2008. J. Biochem. 144: 313-321.

PMID: # 18280257  Kiningham, KK. et al. 2008. Free Radic. Biol. Med. 44: 1610-1616.

PMID: # 17596541  Soriano, AO. et al. 2007. Blood. 110: 2302-2308.

PMID: # 17283134  Ohnuma-Ishikawa, K. et al. 2007. Cancer Res. 67: 1019-1029.

Citations 1 à 10 sur un total de 12
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 132ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 11ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. est leader mondial dans le développement de produits pour la recherche biomédicale. Contactez-nous au 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. Tous Droits Réservés. "Santa Cruz Biotechnology", et le logo Santa Cruz Biotechnology, Inc., "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", le logo San Juan Ranch, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", et "EZ Touch" sont des marques déposées de Santa Cruz Biotechnology, Inc.
Toutes les marques sont la propriété de leurs propriétaires respectifs.